A randomized, double-blind, controlled trial of the effects of ivermectin at normal and high doses, given annually or three-monthly, against Onchocerca volvulus: ophthalmological results
- 1 April 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 99 (4), 279-289
- https://doi.org/10.1016/j.trstmh.2004.04.003
Abstract
A three-year randomized, controlled, double-blind trial was conducted in Cameroon to determine whether ivermectin, given at three-monthly intervals and/or at high doses (800 microg/kg), had a greater effect on adult Onchocerca volvulus than standard doses (150 microg/kg annually). As several patients complained of transitory subjective visual problems after treatment, some of them being of an unexpected type, we organized two series of detailed ophthalmological examinations to evaluate whether they were associated with ocular lesions. Analysis showed that these complaints were significantly more frequent in the two groups treated with high doses of ivermectin than in the reference group. In the ophthalmological examinations, the only differences recorded between the groups were a lower prevalence and mean number of microfilariae in the anterior chamber in the groups treated three-monthly, and, at the first examination round, a higher prevalence of early lesions of the iris in the group treated at high doses annually. These findings do not allow us to explain the cause of the transitory ocular complaints, nor why they were more frequent in the groups treated at high doses. However, one may conclude that using doses of ivermectin higher than the standard one should be considered with caution.Keywords
This publication has 33 references indexed in Scilit:
- The Role of Endosymbiotic Wolbachia Bacteria in the Pathogenesis of River BlindnessScience, 2002
- Blue-yellow colour vision in an onchocercal area of northern NigeriaBritish Journal of Ophthalmology, 1998
- The pathogenesis of chorioretinal disease in onchocerciasisParasitology Today, 1997
- Adverse events following mass ivermectin therapy for onchocerciasisTransactions of the Royal Society of Tropical Medicine and Hygiene, 1992
- Safety of and compliance with community-based ivermectin therapyThe Lancet, 1990
- Effect of single-dose ivermectin therapy on human Onchocerca volvulus infection with onchocercal ocular involvement.British Journal of Ophthalmology, 1988
- COMMUNITY-BASED TREATMENT WITH IVERMECTINThe Lancet, 1988
- DOUBLE-BLIND STUDY OF IVERMECTIN AND DIETHYLCARBAMAZINE IN AFRICAN ONCHOCERCIASIS PATIENTS WITH OCULAR INVOLVEMENTThe Lancet, 1985
- Comparison of Ivermectin and Diethylcarbamazine in the Treatment of OnchocerciasisThe New England Journal of Medicine, 1985
- Changes in visual function and in the posterior segment of the eye during treatment of onchocerciasis with diethylcarbamazine citrate.British Journal of Ophthalmology, 1980